Page last updated: 2024-08-17

cycloheximide and chir 258

cycloheximide has been researched along with chir 258 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cao, S; Dong, Z; Li, C; Li, M; Li, X; Liu, N; Liu, Y; Ma, L; Wang, R; Wang, X; Wei, M; Yang, C; Yang, G; Yao, Y	1

Other Studies

1 other study(ies) available for cycloheximide and chir 258

Article	Year
Proteolysis-Targeting Chimera (PROTAC) Modification of Dovitinib Enhances the Antiproliferative Effect against FLT3-ITD-Positive Acute Myeloid Leukemia Cells. Journal of medicinal chemistry, 2021, 11-25, Volume: 64, Issue:22 Topics: Antineoplastic Agents; Apoptosis; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Mutation; Proteasome Endopeptidase Complex; Proteolysis; Quinolones; Reactive Oxygen Species; Signal Transduction; Structure-Activity Relationship; Ubiquitin	2021

Article

Year

Proteolysis-Targeting Chimera (PROTAC) Modification of Dovitinib Enhances the Antiproliferative Effect against FLT3-ITD-Positive Acute Myeloid Leukemia Cells.

Journal of medicinal chemistry, 2021, 11-25, Volume: 64, Issue:22

Topics: Antineoplastic Agents; Apoptosis; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Mutation; Proteasome Endopeptidase Complex; Proteolysis; Quinolones; Reactive Oxygen Species; Signal Transduction; Structure-Activity Relationship; Ubiquitin

2021